The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Brockstedt Dirk G. since 2015.
This trader's CIK number is 1635616.
At the time of last reporting, Brockstedt Dirk G. was the CHIEF SCIENTIFIC OFFICER of Rapt Therapeutics, Inc.. (stock ticker symbol RAPT).
Also see all insider trading activities at Rapt Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2017 | ADRO | 0 | $0 | 0 | $0 | 52,000 | $75,400 |
| 2017 | ADRO | 0 | $0 | 169,791 | $1,633,269 | 164,108 | $142,804 |
| 2016 | ADRO | 0 | $0 | 22,905 | $506,644 | 22,000 | $20,900 |
| 2015 | ADRO | 0 | $0 | 51,470 | $1,486,748 | 62,000 | $69,660 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | RAPT | 0 | $0 | 898 | $20,456 | 8,000 | $49,440 |
| 2023 | RAPT | 0 | $0 | 742 | $16,298 | 0 | $0 |
| 2022 | RAPT | 0 | $0 | 11,310 | $279,799 | 10,590 | $65,444 |
| 2021 | RAPT | 0 | $0 | 32,494 | $865,925 | 28,410 | $176,798 |
| 2020 | RAPT | 0 | $0 | 31,541 | $602,853 | 38,931 | $241,184 |
1. Chinook Therapeutics, Inc. (ADRO)
2. Rapt Therapeutics, Inc. (RAPT)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2017-12-29 | ADRO | Option Ex | 52,000 | 1.45 | 75,400 |
| 2017-12-15 | ADRO | Sale | 65,223 | 8.11 | 529,219 |
| 2017-12-15 | ADRO | Option Ex | 64,108 | 1.45 | 92,956 |
| 2017-12-01 | ADRO | Option Ex | 10,000 | .52 | 5,200 |
| 2017-12-01 | ADRO | Sale | 10,000 | 9.40 | 94,000 |
| 2017-11-10 | ADRO | Option Ex | 1,815 | .52 | 943 |
| 2017-11-10 | ADRO | Sale | 1,815 | 8.01 | 14,543 |
| 2017-11-13 | ADRO | Option Ex | 4,062 | .52 | 2,112 |
| 2017-11-13 | ADRO | Sale | 4,062 | 8.00 | 32,496 |
| 2017-11-06 | ADRO | Option Ex | 4,123 | .52 | 2,143 |
| 2017-11-06 | ADRO | Sale | 4,123 | 8.04 | 33,132 |
| 2017-10-02 | ADRO | Option Ex | 10,000 | .52 | 5,200 |
| 2017-10-02 | ADRO | Sale | 10,000 | 10.59 | 105,870 |
| 2017-09-13 | ADRO | Sale | 3,557 | 10.99 | 39,077 |
| 2017-09-01 | ADRO | Sale | 10,000 | 11.70 | 116,950 |
| 2017-09-01 | ADRO | Option Ex | 10,000 | .52 | 5,200 |
| 2017-08-07 | ADRO | Option Ex | 10,000 | .52 | 5,200 |
| 2017-08-07 | ADRO | Sale | 10,000 | 12.18 | 121,800 |
| 2017-07-03 | ADRO | Option Ex | 10,000 | .47 | 4,730 |
| 2017-07-03 | ADRO | Sale | 10,000 | 11.02 | 110,170 |
| 2017-06-01 | ADRO | Sale | 8,000 | 10.00 | 80,024 |
| 2017-06-01 | ADRO | Option Ex | 8,000 | .52 | 4,160 |
| 2017-05-17 | ADRO | Sale | 1,011 | 9.65 | 9,756 |
| 2017-05-11 | ADRO | Sale | 8,000 | 9.72 | 77,728 |
| 2017-05-11 | ADRO | Option Ex | 8,000 | .52 | 4,160 |
| 2017-04-03 | ADRO | Option Ex | 8,000 | .45 | 3,600 |
| 2017-04-03 | ADRO | Sale | 8,000 | 10.71 | 85,648 |
| 2017-03-09 | ADRO | Option Ex | 8,000 | .45 | 3,600 |
| 2017-03-09 | ADRO | Sale | 8,000 | 11.00 | 88,000 |
| 2017-01-17 | ADRO | Option Ex | 8,000 | .45 | 3,600 |
| 2017-01-17 | ADRO | Sale | 8,000 | 11.86 | 94,856 |
| 2016-05-16 | ADRO | Sale | 905 | 8.20 | 7,420 |
| 2016-01-11 | ADRO | Sale | 22,000 | 22.69 | 499,224 |
| 2016-01-11 | ADRO | Option Ex | 22,000 | .95 | 20,900 |
| 2015-12-16 | ADRO | Option Ex | 12,000 | 1.45 | 17,400 |
| 2015-12-10 | ADRO | Sale | 25,000 | 29.75 | 743,750 |
| 2015-12-10 | ADRO | Option Ex | 25,000 | 1.45 | 36,250 |
| 2015-11-16 | ADRO | Option Ex | 5,953 | .45 | 2,678 |
| 2015-11-17 | ADRO | Option Ex | 19,047 | .70 | 13,332 |
| 2015-11-16 | ADRO | Sale | 7,423 | 27.55 | 204,540 |
| 2015-11-17 | ADRO | Sale | 19,047 | 28.27 | 538,458 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-01-05 | RAPT | Sale | 898 | 22.78 | 20,456 |
| 2023-12-29 | RAPT | Option Ex | 8,000 | 6.18 | 49,440 |
| 2023-01-05 | RAPT | Sale | 742 | 21.97 | 16,298 |
| 2022-05-04 | RAPT | Sale | 720 | 15.05 | 10,836 |
| 2022-04-11 | RAPT | Option Ex | 2,647 | 6.18 | 16,358 |
| 2022-04-11 | RAPT | Sale | 2,647 | 23.05 | 61,013 |
| 2022-03-11 | RAPT | Option Ex | 2,648 | 6.18 | 16,364 |
| 2022-03-11 | RAPT | Sale | 2,648 | 23.91 | 63,313 |
| 2022-02-11 | RAPT | Option Ex | 2,647 | 6.18 | 16,358 |
| 2022-02-11 | RAPT | Sale | 2,647 | 22.47 | 59,478 |
| 2022-01-11 | RAPT | Sale | 2,648 | 32.16 | 85,159 |
| 2022-01-11 | RAPT | Option Ex | 2,648 | 6.18 | 16,364 |
| 2021-12-10 | RAPT | Sale | 2,647 | 30.88 | 81,739 |
| 2021-12-10 | RAPT | Option Ex | 2,647 | 6.30 | 16,676 |
| 2021-11-11 | RAPT | Option Ex | 2,648 | 6.30 | 16,682 |
| 2021-11-11 | RAPT | Sale | 2,648 | 35.69 | 94,507 |
| 2021-10-11 | RAPT | Sale | 2,647 | 30.78 | 81,474 |
| 2021-10-11 | RAPT | Option Ex | 2,647 | 6.18 | 16,358 |
| 2021-09-10 | RAPT | Option Ex | 2,648 | 6.18 | 16,364 |
| 2021-09-10 | RAPT | Sale | 2,648 | 35.78 | 94,745 |
| 2021-08-11 | RAPT | Sale | 2,647 | 31.19 | 82,559 |
| 2021-08-11 | RAPT | Option Ex | 2,647 | 6.18 | 16,358 |
| 2021-07-12 | RAPT | Sale | 2,648 | 33.53 | 88,787 |
| 2021-07-12 | RAPT | Option Ex | 2,648 | 6.18 | 16,364 |
| 2021-05-11 | RAPT | Option Ex | 2,648 | 6.18 | 16,364 |
| 2021-05-11 | RAPT | Sale | 2,648 | 18.19 | 48,167 |
| 2021-05-05 | RAPT | Sale | 2,084 | 21.56 | 44,931 |
| 2021-02-16 | RAPT | Sale | 9,877 | 21.22 | 209,589 |
| 2021-02-16 | RAPT | Option Ex | 9,877 | 6.24 | 61,632 |
| 2021-01-06 | RAPT | Sale | 1,179 | 19.68 | 23,202 |
| 2021-01-05 | RAPT | Sale | 821 | 19.76 | 16,225 |
| 2020-12-30 | RAPT | Option Ex | 9,300 | 6.18 | 57,474 |
| 2020-11-16 | RAPT | Option Ex | 9,877 | 6.24 | 61,632 |
| 2020-11-16 | RAPT | Sale | 9,877 | 17.01 | 168,007 |
| 2020-11-02 | RAPT | Sale | 1,910 | 28.06 | 53,594 |
| 2020-08-17 | RAPT | Sale | 9,877 | 23.60 | 233,097 |
| 2020-08-17 | RAPT | Option Ex | 9,877 | 6.18 | 61,039 |
| 2020-05-15 | RAPT | Option Ex | 9,877 | 6.18 | 61,039 |
| 2020-05-15 | RAPT | Sale | 9,877 | 15.00 | 148,155 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Brockstedt Dirk G. (CHIEF SCIENTIFIC OFFICER of Rapt Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.